How big is the Microbiology Testing Market?

The Microbiology Testing Market size is expected to reach USD 5.65 billion in 2024 and grow at a CAGR of 9.22% to reach USD 8.78 billion by 2029. Read More

What is the current Microbiology Testing Market size?

In 2024, the Microbiology Testing Market size is expected to reach USD 5.65 billion. Read More

Who are the key players in Microbiology Testing Market?

Bio-Rad Laboratories Inc., Abbott Laboratories, Bruker Corporation, Becton Dickinson and Company and F. Hoffmann-La Roche Ltd are the major companies operating in the Microbiology Testing Market. Read More

Which is the fastest growing region in Microbiology Testing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Microbiology Testing Market?

In 2024, the North America accounts for the largest market share in Microbiology Testing Market. Read More

What years does this Microbiology Testing Market cover, and what was the market size in 2023?

In 2023, the Microbiology Testing Market size was estimated at USD 5.17 billion. The report covers the Microbiology Testing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Microbiology Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Microbiology Testing Market - Growth, Size & Trends

Microbiology Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Rapid Microbiology Testing Market Analysis and it is Segmented by Application (Pharmaceutical Application, Diagnostic Application, Food and Beverage Testing Application, Environmental Application, Cosmetic Application, Other Applications), Product (Equipment and Reagents), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments

Microbiology Testing Industry Overview

The microbiology testing market is moderately competitive in nature. The companies have witnessed new product launches, mergers and acquisitions, partnerships, joint ventures, and strategies adopted by the major players to gain a competitive advantage. The companies are also introducing advanced microbiological automated systems that have high throughput and are less time-consuming. Some of the key players include Bio-Rad Laboratories Inc., Abbott Laboratories, Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Bruker Corporation, Hologic Corporation, Danaher Corporation (Cepheid Inc.), Biomerieux SA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Merck KGaA, Shimadzu Corporation, and NEOGEN Corporation, among others.